New hires:
BeiGene named Matt Shaulis as general manager of North America, effective September 25.
Full-service independent pharmaceutical marketing and communications agency RevHealth, a 2024 MM+M Agency 100 honoree, named former 21Grams and Wunderman Thompson Health exec William Martino as chief commercial officer and fellow 21Grams alum Jamie Caprio as managing director of strategy.
Geron appointed Jim Ziegler as chief commercial officer.
Vir Biotechnology hired Jason O’Byrne as CFO.
Reunion Neuroscience added Mark Pollack, MD as chief medical officer.
AbelsonTaylor Group, a 2024 MM+M Agency 100 honoree, hired Justin Zylberman as director of business development.
Latigo Biotherapeutics hired Tim Lugo as CFO.
AAVantgarde named Dr. Jayashree Sahni as chief medical officer.
Neurotechnology company NextSense appointed Apple alum Duy Phan as VP of engineering.
Cue Biopharma brought on Lucinda Warren as chief business officer.
Inizio Evoke president Corrina Safeio left for Avalere Health, a 2024 MM+M Agency 100 honoree.
Affinia Therapeutics named Rami Daoud as chief business and financial officer.
Rivus Pharmaceuticals named Tom O’Neil as CFO.
HAYA Therapeutics named Jordan Shin, MD, PhD as chief medical officer.
Personalized health company Viome created a diagnostics group and hired former Amazon exec Kal Raman to serve as COO of it.
Tonix Pharmaceuticals named Thomas Englese as EVP of commercial operations.
HC Bioscience tapped Simon Tsang, PhD as chief business officer.
WeightWatchers hired Scott Honken as chief commercial officer.
Alicia Zhou, Ph.D. was appointed CEO of Cancer Research Institute.
ADvantage Therapeutics added Dr. William A. Haseltine as strategic advisor.
Novotech appointed Dr. Yooni Kim as managing director for the Asia-Pacific region, effective September 1.
Executive elevations:
Eli Lilly and Company promoted Lucas Montarce to EVP and CFO added him to the company’s executive committee.
Atara Biotherapeutics elevated Dr. Cokey Nguyen to CEO.
Electronic medical record company Canvas Medical promoted president Adam Farren to CEO. Additionally, founder and CEO Andrew Hines will move into the founder and chief technology officer role.
Board appointments:
Latigo Biotherapeutics added Beth Seidenberg and Jim Tananbaum to its board of directors.
Closed Loop Medicine named Luba Greenwood as chair of the board of directors.
Adcentrx Therapeutics announced the formation of its scientific advisory board.
Rivus Pharmaceuticals named Erin Lavelle as a director who will lead the formation of the audit committee.
Creyon Bio named Serge Messerlian and Shaquille Vayda to its board of directors.
Departures:
Amy Emerson resigned as CEO of Lykos Therapeutics.
Josh Neiman, chief commercial officer of North America and Europe at BeiGene, will leave the company to pursue a new entrepreneurial opportunity at a healthcare technology startup.
The Association for Behavioral Health and Wellness announced that CEO Pamela Greenberg is retiring after 26 years on the job.
Miscellaneous:
A Missouri resident who had no contact with animals has tested positive for bird flu, the state’s health agency and Centers for Disease Control and Prevention announced.
Industry veterans Amy Abernethy, MD, PhD and Brad Hirsch, MD launched Highlander Health.
The Princess of Wales completed her course of chemotherapy, months after announcing her diagnosis.
Lilly has reached a multi-year partnership deal with Indiana Fever star Caitlin Clark.
Chinese police have detained five current and former AstraZeneca employees as part of an investigation into possible breaches related to data privacy and importing unlicensed medications.
HIV telehealth company MISTR debuted a social campaign starring Rupaul’s Drag Race star Alyssa Edwards.
